Dual antiplatelet therapy for mild stroke and transient ischemic attack
10.3760/cma.j.issn.1673-4165.2021.07.007
- VernacularTitle:轻型卒中和短暂性脑缺血发作的双重抗血小板治疗
- Author:
Qianqian CUI
1
;
Yufen WANG
Author Information
1. 长治医学院附属和平医院神经内科，长治 046000
- Keywords:
Stroke;
Brain ischemia;
Ischemic attack, transient;
Dual anti-platelet therapy;
Platelet aggregation inhibitors;
Aspirin;
Clopidogrel;
Dipyridamole;
Ticagrelo
- From:
International Journal of Cerebrovascular Diseases
2021;29(7):514-520
- CountryChina
- Language:Chinese
-
Abstract:
Patients with mild stroke and transient ischemic attack (TIA) have a high risk of early recurrence or deterioration. Antiplatelet therapy has been recognized to reduce the risk of ischemic vascular events. All guidelines recommend antiplatelet therapy for patients with ischemic stroke. Dual antiplatelet therapy (DAPT) refers to the application of two drugs with different mechanisms to block platelet aggregation and prevent thrombosis. There are many combinations of DAPT, and its safety and effectiveness are still uncertain. This article reviews the efficacy and safety of DAPT in patients with mild stroke and TIA.
